Abbott has received 510(k) clearance from the US Food and Drug Administration for both the Abbott RealTime Chlamydia trachomatis/Neisseria gonorrhoeae assay and the Abbott m2000 real-time PCR system, which are required to be used together as a system to detect CT/NG from multiple specimen types including urine, urethral, vaginal and endocervical swabs.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.